EAGLE PHARMACEUTICALS, INC. — Form D
EAGLE PHARMACEUTICALS, INC. of WOODCLIFF LAKE, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2016-11-23. The offering totals $50.7M, of which $2.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-11-23
- Form: D
- Accession: 0000827871-16-000081
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $50.7M
- Amount sold: $2.7M
- Remaining: $48.0M
- Investors: 2
- Date of first sale: 2016-11-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-275107
Issuer
- Name: EAGLE PHARMACEUTICALS, INC.
- CIK: 0000827871
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 50 TICE BOULEVARD, SUITE 315, WOODCLIFF LAKE, NJ, 07677
- Phone: 201-326-5300
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Douglas L Braunstein | Director | New York, NY |
| Sander E Flaum | Director | WOODCLIFF LAKE, NJ |
| Robert L Glenning | Director | WOODCLIFF LAKE, NJ |
| Michael E Graves | Director | WOODCLIFF LAKE, NJ |
| David E Pernock | Director | WOODCLIFF LAKE, NJ |
| Steven E Ratoff | Director | WOODCLIFF LAKE, NJ |
| Scott Tarriff | Director | Rockville, MD |
| Adrian E Hepner | Executive Officer | WOODCLIFF LAKE, NJ |
| Steven L Krill | Executive Officer | WOODCLIFF LAKE, NJ |
| David E Riggs | Executive Officer | Tomball, TX |
| Scott Tarriff | Executive Officer | Rockville, MD |
| Scott L Tarriff | Director | Ann Arbor, MI |
| Scott L Tarriff | Executive Officer | Ann Arbor, MI |
| Gregg C Stetsko | Executive Officer | Woodcliff Lake, NJ |
| John C Deighan | Executive Officer | Woodcliff Lake, NJ |
Other filings by this issuer (1)
More